Cannabis: Near-term caution remains, Aphria still among top picks -Jefferies

** Jefferies maintains cautious stance on near-term outlook
for Canada's cannabis industry, citing expected petering out of
sales after recent "pantry loading," falling prices and likely
coronavirus-led hit to supply
    ** Brokerage adds short-term profitability and cash will
become more important in a recession, with dilutive raises or
bankruptcies in coming months also likely to weigh on sentiment 
    ** Jefferies estimates Canadian industry sales in 2020 will
total C$2.3 bln, vs. consensus estimate of C$3 bln as of January
    ** Brokerage says Aphria Inc  APHA.TO  and OrganiGram
Holdings Inc  OGI.TO  stay as top picks, with little cash risk,
strong market share and financials
    ** Jefferies upgrades Canopy Growth Corp  WEED.TO  to "hold"
from "underperform" following recent sell-off; says it should be
better placed in a COVID/recession environment than many peers
due to its strong balance sheet 
    ** Brokerage downgrades Tilray Inc  TLRY.O  to
"underperform" from "hold," saying its valuation is too rich
compared with its near-term business outlook
    ** Up to Wednesday's close, shares of CRON, APHA, WEED, OGI,
TLRY, HEXO have fallen between 17%-60% this year
    
 Company                  RIC         New PT      Old PT
 Canopy Growth             WEED.TO    C$22        C$23
 Aphria                    APHA.TO    C$9         C$10
 OrganiGram                OGI.TO     C$5         C$5.50
 Cronos                    CRON.O     $4.80       $5.30
 Hexo                      HEXO.TO    C$0.50      C$1
 Aurora Cannabis           ACB.TO     C$1         C$1.90
 Green Organic Dutchman    TGOD.TO    C$0.16      C$0.15
 Flowr Corp                FLWR.V     C$2.10      C$2.60
 Tilray                    TLRY.O     $5          $3.80
 

 (Reporting by Shanti S Nair in Bengaluru)
 ((ShantiS.Nair@thomsonreuters.com))

Recent news on Bzam

See all news